Brazilian pharma firm to produce Pfizer/BioNTech vaccine for distribution in Latin America

The Pfizer-BioNTech vaccine is used in 120 countries. In Brazil, it was the first to obtain the definitive registration by ANVISA, a status granted in February and which only this month was obtained in the United States.

RIO DE JANEIRO, BRAZIL - The consortium of the U.S. pharmaceutical company Pfizer and the German laboratory BioNTech announced Thursday (26) an agreement with the Brazilian multinational Eurofarma for the local production of its Covid-19 immunizer and its distribution in Latin America.

"Eurofarma will carry out manufacturing activities within the global Covid-19 vaccine supply chain and production network that Pfizer and BioNTech have, which now extends to 4 continents and will include 20 manufacturing units," the Brazilian pharmaceutical company said in a statement.

The agreement provides for "technical transfer, local development, and installation of equipment", actions that "will . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?